NEW YORK, NY / ACCESS Newswire / December 30, 2025 / – SueWallSt: Class Action Filed Against Stride, Inc. – Contact Levi & Korsinsky A Class Action lawsuit was filed on behalf of investors who lost money as a result of alleged securities fraud between October 22, 2024 and October 28, 2025. If you suffered […]
NEW YORK CITY, NY / ACCESS Newswire / December 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ultragenyx and certain of its officers and/or
Vancouver, British Columbia–(Newsfile Corp. – December 30, 2025) – Mineral Road Discovery Inc. (CSE: ROAD) (the "Company" or "ROAD") announces that, further to its news release of December 22, 2025, it has issued to Mineral Road Partners Inc. ("MR Partners") an aggregate of 5,000,000 units (the "Units") at a deemed price of $0.10 per Unit
NEW YORK, NY / ACCESS Newswire / December 30, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Synopsys, Inc. (NASDAQ:SNPS) between December 4, 2024 and September 9, 2025, both dates inclusive (the "Class Period"), of the important December 30, 2025 lead plaintiff deadline. SO WHAT: If
Toronto, Ontario–(Newsfile Corp. – December 30, 2025) – Deveron Corp. (TSXV: FARM) (“Deveron” or the “Company“) is pleased to announce the results of its special meeting of shareholders (the “Meeting“) held on December 30, 2025. At the Meeting, shareholders voted in favour of all resolutions brought before the Meeting. Details of all resolutions that were
NEW YORK CITY, NY / ACCESS Newswire / December 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Organogenesis Holdings Inc. ("Organogenesis" or the "Company") (NASDAQ:ORGO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Organogenesis and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / December 30, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Inovio Pharmaceuticals, Inc. ("Inovio" or the "Company") (NASDAQ:INO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Inovio and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / December 30, 2025 / – SueWallSt: Class Action Filed Against Firefly Aerospace Inc. – Contact Levi & Korsinsky This lawsuit is on behalf of a class consisting of all persons and entities other than defendants that purchased or otherwise acquired: (a) Firefly common stock pursuant and/or traceable to
Calgary, Alberta–(Newsfile Corp. – December 30, 2025) – NCM Asset Management Ltd., the manager of a strategically focused group of public mutual funds and alternative funds (“NCM Investments”), announced today that distributions have been declared for the following funds: $3.7094 per unit* for NCM Dividend Champions $0.9204 per unit* for NCM Global Income Balanced Portfolio
NEW YORK CITY, NY / ACCESS Newswire / December 30, 2025 / WHY: New York, N.Y., December 30, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stride, Inc. (NYSE:LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the "Class Period"), of the important January 12,